Neoadjuvant therapy for gallbladder cancer: current status and challenge

Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 2

Abstract

Gallbladder cancer is one of highly malignant digestive system tumors with insidious symptoms, rapid progression, and poor prognosis. Although radical resective surgery is the only possible curative way for gallbladder cancer, most patients have lost the opportunity to undergo surgery when diagnosed. The neoadjuvant therapy had been used for many malignant tumors in digestive system including pancreatic cancer. The neoadjuvant therapy also had been used for gallbladder cancer including chemotherapy, radiation therapy, immunotherapy and molecular targeted therapy in the treatment of patients with advanced gallbladder cancer, and has achieved some effects. A few patients benefited from downstaging and got the opportunity to have R0 resection after neoadjuvant therapy. However, there are still many controversies and challenges, including the inconsistent criteria for evaluation of resectable gallbladder cancer, the absence of standardized protocols for neoadjuvant therapy, increasing rate of postoperative complications after neoadjuvant therapy compared to the patients undergoing direct surgery, and lack of criteria of both indications and evaluated effects of neoadjuvant therapy. Therefore, it should still need more high-quality prospective clinical trials to resolve these controversies and clinical applications.

Authors and Affiliations

Ying XING, Shi CHENG

Keywords

Related Articles

Proceedings of clinical trials on bile tract cancer

Bile tract cancer (BTC) is aggressive and difficult to diagnose at an early stage. So far, radical surgery is the main curative measure for BTC, most patients with BTC are already in progressive or advanced stage at the...

Nutritional therapy recommendations for patients with coronavirus disease 2019 (COVID-19) in Ruijin Hospital (2023 edition)

Nutritional support is one of the comprehensive treatments for the patients with novel coronavirus infection, especially for critically ill patients. Nutritional therapy needs to follow the standard process, which includ...

The strategy of extrahepatic organs management in early period after adult liver transplantation

With the improvements in surgical technique, the indications for liver transplantation(LT) are being expanded to more complex and severe patients, who not only have liver function in the terminal stage, but also extrahep...

Etiological analysis of elevation of bile amylase level in patients with normal pancreaticobiliary junction and endoscopic treatment

[Objective] To investigate the cause of elevation of bile amylase level in patients with normal pancreaticobiliary junction and the effect of endoscopic treatment. [Methods] The clinical data of 96 patients with normal p...

Download PDF file
  • EP ID EP750853
  • DOI 10.16139/j.1007-9610.2023.02.05
  • Views 33
  • Downloads 0

How To Cite

Ying XING, Shi CHENG (2023). Neoadjuvant therapy for gallbladder cancer: current status and challenge. Journal of Surgery : Concepts & Practice, 28(2), -. https://www.europub.co.uk/articles/-A-750853